check_circleStudy Completed
Diabetes Mellitus
Bayer Identifier:
14284
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
GlucoVIP - Diabetes treatment by Glucobay® with a special therapeutic view to chosen patient groups
Trial purpose
Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in a large sample of patients.
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
15729Trial Dates
March 2009 - December 2010Phase
N/ACould I Receive a placebo
NoProducts
Precose/Glucobay (Acarbose, BAYG5421)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Russia | |
Completed | Many Locations, China | |
Completed | Many Locations, Indonesia | |
Completed | Many Locations, Hong Kong | |
Completed | Many Locations, Malaysia | |
Completed | Many Locations, Thailand | |
Terminated | Many Locations, Moldova | |
Completed | Many Locations, Korea, Republic Of | |
Completed | Many Locations, India | |
Completed | Many Locations, Philippines | |
Completed | Many Locations, Singapore | |
Completed | Many Locations, Pakistan | |
Completed | Many Locations, Cambodia | |
Completed | Many Locations, Viet Nam | |
Completed | Many Locations, Bosnia and Herzegovina | |
Completed | Many Locations, Algeria |
Primary Outcome
- Data collection on patients weight and waist circumference, fasting blood glucose, postprandial blood glucose (2h), HbA1C; exploratory analysis according to patient groups (concomitant cardiovascular disease groups, BMI)date_rangeTime Frame:During observation period of three monthsenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A